Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abdulalh Sonsuz"'
Autor:
Burcu Arslan, Halis Şimşek, Salih Tokmak, Ali Demir, Abdulalh Sonsuz, Hikmet Akkiz, Tuncer Temel, Gökhan Karakülah, Engin Altintaş, Ahmet Bektaş, Brian I. Carr, Figen Doran, Sezai Yilmaz, Tolga Akcam, Oğuz Üsküdar, Y. Tokat, Aslı Suner, Mehmet Demir, Tuğsan Ballı, Necati Örmeci, Mehmet Yücesoy, Ahmet Uygun, Sedef Kuran, Anıl Delik, Murat Kilic, Abdulalh Ülkü, Halil İbrahim Bahçeci, Nazım Ekinci, Ayşegül Özakyol, Kamil Yalçın Polat, Kendal Yalcin
Publikováno v:
Journal of translational science
Introduction Several markers of systemic inflammation, including blood C-reactive protein, platelet lymphocyte ratio (PLR) and neutrophil lymphocyte ratio (NLR) have been identified as independent prognosticators for hepatocellular carcinoma (HCC). M
Autor:
Brian I, Carr, Hikmet, Akkiz, Vito, Guerra, Oguz, Üsküdar, Sedef, Kuran, Ümit, Karaoğullarından, Salih, Tokmak, Tuğsan, Ballı, Abdulalh, Ülkü, Tolga, Akçam, Anıl, Delik, Burcu, Arslan, Figen, Doran, Kendal, Yalçın, Engin, Altntaş, Ayşegül, Özakyol, Mehmet, Yücesoy, Halil İbrahim, Bahçeci, Kamil Yalçın, Polat, Nazım, Ekinci, Halis, Şimşek, Necat, Örmeci, Abdulalh, Sonsuz, Mehmet, Demir, Murat, Kılıç, Ahmet, Uygun, Ali, Demir, Sezai, Yilmaz, Yaman, Tokat
Publikováno v:
Clinical practice (London, England). 15
C-reactive protein (CRP) is a blood marker for inflammation and is an independent prognostic factor for many human cancers. Combined with albumin levels, it forms the basis of the Glasgow Index for cancer prognosis. We reviewed the literature on CRP
Autor:
Tuncer Temel, Burcu Arslan, Figen Doran, Kendal Yalcin, Abdulalh Ülkü, Abdulalh Sonsuz, Anıl Delik, Gökhan Karakülah, Sezai Yilmaz, Aslı Suner, Tuğsan Ballı, Tolga Akcam, Necati Örmeci, Ali Demir, Ayşegül Özakyol, Murat Kilic, Y. Tokat, Hikmet Akkiz, Brian I. Carr, Halil İbrahim Bahçeci, Halis Şimşek, Salih Tokmak, Ahmet Bektaş, Oğuz Üsküdar, Engin Altintaş, Kamil Yalçın Polat, Mehmet Demir, Mehmet Yücesoy, Sedef Kuran, Ahmet Uygun, Nazım Ekinci
Publikováno v:
Oncology. 96(1)
EgeUn###
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated in about half of the HCC patients, limiting its usefulness in following the effects of therapy or screening. New markers are needed. It has been pr
The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated in about half of the HCC patients, limiting its usefulness in following the effects of therapy or screening. New markers are needed. It has been pr
Autor:
Anıl Delik, Halil İbrahim Bahçeci, Kamil Yalçın Polat, Tuğsan Ballı, Murat Kilic, Brian I. Carr, Oğuz Üsküdar, Ümit Karaoğullarından, Halis Şimşek, Mehmet Yücesoy, Sedef Kuran, Hikmet Akkiz, Necati Örmeci, Kendal Yalcin, Mehmet Demir, Sezai Yilmaz, Nazım Ekinci, Ayşegül Özakyol, Guerra, Ahmet Uygun, Figen Doran, Y. Tokat, Ali Demir, Salih Tokmak, Altntaş E, Tolga Akcam, Burcu Arslan, Abdulalh Ülkü, Abdulalh Sonsuz
Publikováno v:
Hyldahl, S, Grønlund, D, Drewes, A & Brock, C 2018, ' The patient burden of opioidinduced bowel dysfunction ', Clinical Practice (Therapy), vol. 15, no. 4, pp. 775-784 . https://doi.org/10.4172/clinical-practice.1000409
C-reactive protein (CRP) is a blood marker for inflammation and is an independent prognostic factor for many human cancers. Combined with albumin levels, it forms the basis of the Glasgow Index for cancer prognosis. We reviewed the literature on CRP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8cac12c7b672d65eea2f70e98b6fab
https://vbn.aau.dk/da/publications/f16124b3-98d1-41ca-a9dd-3645c025a754
https://vbn.aau.dk/da/publications/f16124b3-98d1-41ca-a9dd-3645c025a754